Hi Mikeo! We're pretty similar in diagnosis. I just turned 70, had a single 4+3 core, prostate smaller, PSA max was 3.4. I'm being treated at Mayo Jax by SBRT. We were debating adding any ADT and my RO wanted to see my genetic prostate score before making a recommendation. Unfortunately, it came back at .69 putting me in the high risk group. Given that, I'm adding 6 month of Orgovyx. Had Orgovyx not been an option, I don't think I would have done any ADT due to the higher risk profile of the other drugs. Given Orgovyx is a daily oral and recovery is much quicker than previous drugs, I was more comfortable giving it a go. My RO believes it will reduce my risk of distant metastasis in the next 10 years by half. I did read the articles you mentioned. Although the study showed no significant improvement in overall survival with the addition of short-term androgen-deprivation therapy (ADT) to dose-escalated radiotherapy in patients with intermediate-risk prostate cancer. Benefits were observed in rates of metastases, prostate cancer–specific mortality, and prostate-specific antigen (PSA) failure. Hopefully I'll have a chance to chat with you in 10 years and we can better assess our decision making (-: Best wishes!